This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Bemrist Breezhaler — Description, Dosage, Side Effects | PillsCard
OTC
Bemrist Breezhaler
INN: indacaterol;mometasone
Data updated: 2026-05-14
Available in:
🇨🇿🇩🇪🇬🇧🇯🇵🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Novartis Europharm Limited
ATC Code
R03AK
Source
EMA · EMEA/H/C/005516
R03AK14(WHO)
CA:℞-onlyEU:Rx-onlyIn general: ℞ (Prescription only)
D11862
Indacaterol/mometasone, sold under the brand nameAtectura Breezhaleramong others, is afixed-dose combinationmedication for the treatment ofasthmain adults and adolescents twelve years of age and older not adequately controlled with inhaledcorticosteroidsand inhaled short actingbeta2agonists.
The most common side effects include worsening ofasthmaandnasopharyngitis(inflammation in the nose and throat).Other common side effects include upper respiratory tract infection (nose and throat infections) and headache.Indacaterol/mometasone was approved for medical use in the European Union in May 2020,and in Japan in June 2020.